INTRODUCTION
During acute infection, pathogenic viruses target numerous organs to facilitate replication and dissemination. The mechanisms of organ-specific control of virus infection are poorly understood.
The b-herpesvirus murine cytomegalovirus (MCMV) has coevolved with its mammalian host over millions of years, providing a paradigm of a well-adapted persistent virus that has been extensively exploited in studies of host-pathogen interactions in vivo. MCMV also provides the most tractable in vivo model for the pathogenic b-herpesvirus human cytomegalovirus (HCMV), exhibiting many parallels in terms of pathogenesis, host immunity, immune evasion, and broad tissue tropism (Shellam et al., 2006) . NK cells are a key component of the innate immune response and are critical for the control of human herpesviruses, a control that has been elegantly modeled in MCMV (Biron et al., 1989; Bukowski et al., 1984) . Importantly, however, the antiviral role of NK cells can be both cell-type and organ specific. For example, NK cell depletion preferentially increases MCMV progeny derived from endothelial cells as compared with nonendothelial cell-derived virus, and this effect is more profound in the lung versus other sites of infection (Sacher et al., 2012) . Moreover, NK cells in the salivary gland, which represents a key site of MCMV persistence and dissemination, are hyporesponsive to MCMV infection (Tessmer et al., 2011) .
Studies in MCMV also highlight the pivotal role for cytokines such as type I interferons (IFNab), lymphotoxin, IL-12, and IL-18 in either inhibiting viral replication directly or regulating the development of innate and adaptive immunity (Andoniou et al., 2005; Andrews et al., 2003; Banks et al., 2005; Orange and Biron, 1996) . However, restricted expression of such cytokines in MCMV-infected tissues is observed (Schneider et al., 2008) . Collectively, these data are consistent with the existence of additional antiviral effector mechanisms that counter CMV in a broad range of cells within a plethora of tissue microenvironments.
Interleukin-22 (IL-22) is an important effector cytokine in peripheral tissues. IL-22 is expressed by numerous innate and adaptive immune cells and signals through the IL-22Ra/IL10Rb dimeric receptor (Sonnenberg et al., 2011) . While IL10Rb is ubiquitously expressed, IL-22Ra expression is restricted to nonhematapoetic cells, with elevated expression in tissues such as the oral/gastrointestinal tract, lung, skin, kidney, and liver (Wolk et al., 2004) .
IL-22 contributes to the immune control of gram-negative bacterial infections at mucosal surfaces while also exhibiting tissue-protective functions (Aujla et al., 2008; Zenewicz et al., 2007; Zheng et al., 2008) . The role of IL-22 in viral infections is less well defined. IL-22 neutralization does not impair protection from influenza infection in mice (Guo and Topham, 2010) and, in certain viral infection models, can heighten inflammation without influencing virus clearance (Zhang et al., 2011) . In contrast, IL-22 is cytoprotective in the liver during arenavirus chronicity (Pellegrini et al., 2011) . CD161 + T cells that express IL-22 are enriched in the liver during chronic hepatitis C virus (HCV) infection (Billerbeck et al., 2010; Kang et al., 2012) , and the single nucleotide polymorphism IL-22-rs1012356 SNP is associated with protection from HCV (Hennig et al., 2007) . IL-22 has also been implicated in direct inhibition of dengue virus replication (Guabiraba et al., 2013) and T cell-mediated protection from horizontal HIV transmission (Missé et al., 2007) . Consequently, a consensus is beginning to emerge that IL-22 may exert antiviral control during infection.
To investigate this, we utilized the MCMV model to elucidate the role that IL-22 plays in viral infection of peripheral tissue. Our results reveal a previously unanticipated mechanism through which IL-22 impacts on virus-induced immune responses and a potent effector mechanism that counters herpesvirus infection.
RESULTS

IL-22 Affords Tissue-Restricted Protection from MCMV Infection
During primary infection, MCMV targets multiple organs of the secondary lymphoid tissue (e.g., spleen), mucosa (e.g., lung), and nonmucosa (e.g., liver). IL-22R mRNA is expressed predominantly in barrier surfaces and also in the liver (Wolk et al., 2004) . In accordance, IL-22R was expressed in murine lung and liver, and expression was further elevated in the liver and, to a lesser extent, the lung in response to MCMV ( Figure 1A ). No significant IL-22R expression was detected in the spleen before or after MCMV infection ( Figure 1A ). Histological analysis of mice expressing LacZ under the control of the Il-22ra1 promoter demonstrated IL-22R expression within the lung, particularly by epithelial cells (see Figure S1 available online). Moreover, IL-22R expression by cells with large nuclei, indicative of hepatocytes, was detectable throughout the liver ( Figure S1 ).
Given that IL-22R was expressed in mucosal and hepatic sites targeted by MCMV, we hypothesized that IL-22 influenced the outcome of acute infection. To test this, MCMV-infected mice were treated with either an IL-22-blocking antibody (aIL-22) or IgG control. IL-22 neutralization markedly increased infectious virus load in the liver as early as 2 days after infection ( Figure 1B ). In the lung, low levels of virus infection occur within the first 2 days of infection, as demonstrated by detection of infectious virus in only four of ten IgG-treated mice ( Figure 1C ). After aIL-22 treatment, however, virus was detected in eight of ten lungs, seven of which demonstrated higher virus load than IgG-treated mice ( Figure 1C) , highlighting an antiviral function for IL-22 during initial infection and suggesting it sets a threshold for acute virus replication in the lung. Consistent with low IL-22R expression in the spleen ( Figure 1A ), IL-22 neutralization did not influence virus replication in this organ ( Figure 1D ). Despite this tissue-restricted antiviral role for IL-22, the global effect of IL-22 was demonstrated by exacerbated weight loss in aIL-22-treated mice ( Figure 1E ). Thus, IL-22 limits MCMV infection in an organ-specific manner that is determined by IL-22R expression, and restricts clinical signs of virus-induced disease.
Conventional NK Cells, NK T Cells, and T Cells Are Significant Sources of IL-22 in MCMV Infection MCMV infection enhanced IL-22 production in the liver and lung (Figure 2A ). Conventional NK1.1 + NK cells and NK T cells secrete IL-22 in virus infections (Guo and Topham, 2010; Juno et al., 2012; Kumar et al., 2013) , and NK1.1 depletion during MCMV infection abrogated IL-22 protein production in the liver and lung ( Figure 2A ). Furthermore, T cells produce IL-22 in certain infections (Sonnenberg et al., 2011) , and codepletion of CD4 + and CD8 + cells (which includes CD4 + NK T cells) also reduced IL-22 production ( Figure 2A ). NK1.1 or CD4/CD8 depletion reduced IL-22 protein concentrations below those detected in naive tissue. This may reflect higher IL-22 turnover upon infection due to increased IL-22R expression ( Figure 1A ) and/or RORgT ( Figure 2E ). Moreover, pulmonary and hepatic IL-22 + NK cells expressed granzyme B, many of which coexpressed IFN-g, suggesting conventional NK cell function ( Figure S2D ). Indeed, a significant proportion of IL-22 + NK cells coexpressed CD27 and CD11b (Figures S2E and S2F), indicating high cytotoxic capacity (Hayakawa and Smyth, 2006) . Addition of IL-23, the receptor for which is not expressed by conventional NK cells (Cohen et al., 2013) , did not increase IL-22 + NK cell frequency detected after incubation with PMA/ionomycin ( Figure S2G 
IL-22 Promotes Accumulation of Neutrophils in Peripheral Tissue
The mechanisms through which IL-22 exerted antiviral control were next investigated. Preincubation of an IL-22R-expressing epithelial cell line (SGC1) with IL-22 did not inhibit MCMV replication (data not shown). Moreover, aIL-22 did not influence antiviral IFN (type I and II), lymphotoxin, TNF-a, IL-18, IL-1b, or IL-6 expression, nor did it influence serum amyloid A (SAA) secretion in livers and lungs day 2 p.i. (data not shown); the time point at which IL-22 first displayed antiviral activity. NK cell accumulation and ex vivo degranulation and IFN-g expression in the lung and liver were unaltered after aIL-22 treatment (data not shown). Moreover, macrophage and monocyte accumulation within MCMV-infected organs was unaffected by aIL-22 treatment ( Figures 3A-3C ). Strikingly, however, accumulation of neutrophils, which represented a substantial proportion of the MCMV-elicited leukocyte infiltrate in the liver ( Figure 3D ) and lung ( Figure 3E ) 2 days p.i., was substantially reduced in both organs after IL-22 neutralization ( Figures 3A, 3B , 3D, and 3E). In the spleen, however, aIL-22 did not influence neutrophil accumulation in this IL-22-refractory site (Figures 3C and 3F) .
Murine CXCL1 (KC) is the main neutrophil-activating chemokine (Sadik et al., 2011) , and in vivo administration of an aCXCL1 neutralizing antibody restricted neutrophil accumulation in the liver ( Figure 3G ) and lung ( Figure 3H ). In contrast, aCXCL1 increased neutrophil accumulation in the spleen ( Figure 3I ), consistent with the hypothesis that neutrophil migration into the lung and liver is controlled by different mechanisms to those in the spleen. IL-22 induced secretion of CXCL1 by IL-22R + SGC1 cells by 6 hr poststimulation ( Figure 3J ), and crucially, aIL-22 reduced CXCL1 protein concentrations in the liver ( Figure 3K ) and lung ( Figure 3L ) 2 days p.i., suggesting that early induction of CXCL1 secretion by IL-22 is critical for chemokinedriven neutrophil recruitment. Consistent with the low IL-22R expression in the spleen ( Figure 1A ), aIL-22 did not influence CXCL1 secretion in this organ ( Figure 3M ).
Neutrophils Afford Protection from MCMV Replication In Vivo
The association between the tissue-restricted antiviral activity of IL-22 and neutrophil infiltration implied an antiviral function for this cell population. Upon MCMV infection, neutrophils were detected in high numbers in infected tissues ( Figures 3A-3C) , and a high frequency of activated CD11b
+ cells was present in these infected organs ( Figure 4A ), demonstrating that these cells were activated during MCMV infection. Furthermore, histological analysis of MCMV-infected tissue demonstrated that neutrophils localized adjacent to infected cells ( Figure 4B ). To test whether neutrophils contributed to antiviral immunity, MCMV-infected mice were administered with a Ly6G-specific monoclonal antibody that specifically depleted neutrophils without affecting inflammatory monocyte/macrophage populations ( Figure 5A ). Strikingly, antibody-mediated depletion of neutrophils increased MCMV-induced weight loss ( Figure 5B ). This exacerbation of virus-induced illness was associated with elevated virus load in liver ( Figure 5C ) and lungs ( Figure 5D ), but not the spleen ( Figure 5E ). C57BL/6 mice lacking adaptive immunity control acute MCMV infection, a process mediated in part by Ly49H-expressing NK cells recognizing MCMV m157 protein (French et al., 2004) . Strikingly, we observed that depletion of neutrophils in MCMVinfected RAG À/À mice triggered dramatic weight loss ( Figure 5F ) and a concurrent large elevation in replicating virus in the livers ( Figure 5G ) and lungs ( Figure 5H ). Interestingly, in this model where $14% of splenocytes prior to MCMV infection are Ly6G + neutrophils, depletion of these cells also increased replicating virus detected in the spleen ( Figure 5I ). Thus, neutrophils are critical early antiviral effector cells during CMV infection in vivo.
Neutrophils Directly Inhibit MCMV Replication
We characterized the mechanistic control of MCMV by neutrophils. Neutrophil crosstalk with NK cells promotes NK cell development, including enhanced NK cell cytotoxicity (Jaeger et al., 2012) . However, as mentioned earlier, the accumulation of cytotoxic NK cells was not affected by aIL-22 (data not shown), and neutrophil depletion did not impair NK cell accumulation, cytotoxicity or IFN-g expression ( Figure S3 ). Furthermore, concurrent depletion of both neutrophils and NK cells exhibited an additive antagonistic effect on host control of infection ( Figure 6A ). Of note, NK depletion did not influence neutrophil accumulation in infected tissues (data not shown). Taken with the observations that T cells secrete IL-22 (Figures 2A-2C ) and that MCMV replication (which is elevated after NK1.1 depletion in this model [Stacey et al., 2011] ) directly induces CXCL1 production (Figure 3J ), these results demonstrate that NK1.1 À cells are capable of promoting neutrophil recruitment in the absence of NK cells. Importantly, these results also imply that neutrophil activation of NK cells is not the primary mechanism through which neutrophils control MCMV. We investigated whether neutrophils were capable of direct antiviral activity. Coincubation of purified neutrophils ( Figure 6B ) with 3T3 fibroblasts led to $50% neutrophil viability for up to 72 hr and, interestingly, we observed a trend in elevated neutrophil viability following coincubation with MCMV-infected cells ( Figure 6C ). Crucially, neutrophil coincubation with MCMVinfected fibroblasts dramatically reduced the production of replicative virions in a cell-number-dependent manner ( Figure 6D ), demonstrating that neutrophils directly inhibit MCMV replication.
Neutrophils Exert Anti-MCMV Activity in a TRAILDependent Manner
To identify the mechanism(s) through which neutrophils exert antiviral activity, expression of putative antiviral effector molecules by hepatic neutrophils isolated 2 days p.i. was measured. We detected no expression of type I and II interferons, perforin, and lymphotoxin by MCMV-induced neutrophils ( Figure S4A ). However, MCMV-induced neutrophils expressed significant iNOS, TNF-a, TRAIL, and low but reproducibly detectable FasL mRNA ( Figure S4A ). Gene expression analysis in whole tissue revealed that all four genes were upregulated upon MCMV infection in vivo ( Figure 7A ).
The effect of antagonizing each of these molecules on antiviral neutrophil activity was next assessed. Strikingly, inhibition of the death receptor ligand TRAIL dramatically abrogated the antiviral activity of neutrophils ( Figure 7B ) without influencing neutrophil survival ( Figure S4B ). In addition, FasL blockade moderately antagonized neutrophil-mediated control of MCMV, although this was not statistically significant ( Figure 7B ). Further, soluble TRAIL ( Figure 7C ) and, to a lesser extent, soluble FasL ( Figure 7D ) inhibited MCMV replication, further implying a dominant role for TRAIL in facilitating neutrophil-mediated antiviral control. Indeed, TRAILR (DR5) was upregulated by MCMV-infected fibroblasts in vitro 6 hr p.i., although expression was downregulated by 24 hr with complete reversal of TRAILR expression by 48 hr ( Figure 7E ). In contrast, we observed no significant regulation of Fas by MCMV (data not shown). Collectively, these results pointed toward a dominant role for TRAIL in the anti-MCMV function of neutrophils and are consistent with the observation that CMVs actively downregulate surface TRAILR expression (Smith et al., 2013) . Furthermore, in accordance with complete downregulation of TRAILR expression by 48 hr, delaying the addition of neutrophils ( Figure 7F ) or soluble TRAIL ( Figure S4C ) to MCMV-infected fibroblasts until this time point abrogated antiviral activity.
We next investigated whether TRAIL expression by neutrophils contributed to antiviral control in vivo. In accordance with infection-induced TRAIL mRNA expression ( Figure 7A ), MCMV induced cell-surface TRAIL expression by neutrophils (Figure 7G) . We inhibited TRAIL/TRAILR interactions in vivo with blocking aTRAIL antibody in NK-depleted RAG À/À mice, thus Figure 7H ). Importantly, TRAIL blockade increased MCMV burden to comparable levels measured in neutrophildepleted mice ( Figure 7H ). Critically, antagonizing both TRAIL and neutrophils did not further abrogate antiviral protection ( Figure 7H ), providing evidence that neutrophils limit MCMV replication in vivo via TRAIL. Finally, neutralization of IL-22 in neutrophil-depleted WT mice failed to further increase virus load as compared to aLy6G treatment alone, suggesting that IL-22 exerts antiviral control via neutrophil recruitment ( Figure 7I ). Consistent with this hypothesis, IL-22 neutralization, which resulted in an $2-fold reduction in neutrophil recruitment, had a lesser impact on antiviral control than Ly6G depletion (Figure 7I) . Collectively, these results demonstrate that IL-22 drives antiviral neutrophil response in vivo, and that TRAIL is a significant mechanism through which neutrophils restrict MCMV replication.
DISCUSSION
We identified neutrophils as potent antiviral effector cells that restrict CMV infection of peripheral tissue and exert antiviral activity via TRAIL. In addition, we identified IL-22 as an important component of the antiviral immune response that recruits neutrophils to peripheral sites of MCMV infection in which IL-22R is expressed. Thus, the IL-22-neutrophil axis represents a pathway that counteracts virus invasion of peripheral tissues. The role that neutrophils play in viral infections is not well appreciated. Depletion of Ly6G + cells during influenza infection revealed that neutrophils limit influenza-induced illness, although it is not clear whether neutrophils directly impinge on virus replication (Tate et al., 2009 (Tate et al., , 2011 . Paradoxically, neutrophils are associated with influenza-induced inflammation (La Gruta et al., 2007) , particularly during infection with highly pathogenic strains (Perrone et al., 2008) . In contrast to MCMV, neutrophils support West Nile virus replication, while depletion experiments suggested that neutrophils exert antiviral control during later stages of acute infection (Bai et al., 2010) . Moreover, neutrophil extracellular traps capture HIV and promote virus killing via myeloperoxidase and a-defensin (Saitoh et al., 2012) and limit poxvirus infection in vivo (Jenne et al., 2013) . Neutrophils also kill HIV-infected CD4 + T cells via antibody-dependent cellular cytotoxicity (Smalls-Mantey et al., 2013) . Intriguingly, in the context of herpesviruses, neutropenia has been identified as a risk factor for occurrence of herpesvirus infections in immunesuppressed individuals (Jang et al., 2012; Lee et al., 2012) . Importantly, depletion in mice of cells expressing Gr1, which is expressed by numerous cells including Ly6G + neutrophils (Tate et al., 2009) , elevates HSV replication in the genital mucosa (Milligan, 1999 ) and cornea (Tumpey et al., 1996) . We now provide definitive evidence that neutrophils directly inhibit replication of a pathogenic herpesvirus in vitro and in vivo.
Expression of TRAIL is one mechanism through which neutrophils exert direct antiviral activity in vitro and in vivo. Neutrophils expressed TRAIL on the cell surface, although our data do not preclude the possibility that neutrophils also secrete TRAIL in response to MCMV. HCMV UL141 protein promotes intracellular retention of TRAIL receptors, desensitizing cells to TRAIL-mediated apoptosis (Smith et al., 2013) . We observed TRAILR downregulation in MCMV-infected fibroblasts, consistent with the role of MCMV m166 protein in restricting TRAILR expression (C.A.B, unpublished data). Abrogation of neutrophiland TRAIL-mediated inhibition of MCMV replication after 24 hr suggests neutrophils limit virus replication within the first hours of infection when TRAILR is present on the cell surface. TRAILR downregulation implies viral evasion of TRAIL-induced cell death. However, TRAILR signaling also induces NF-kB- mediated proinflammatory cytokine production (Tang et al., 2009) , suggesting that TRAIL may induce multiple antiviral pathways. Incomplete reversal of neutrophil antiviral activity following TRAIL inhibition suggests additional mechanisms exist through which neutrophils restrict MCMV. Neutrophil exposure to MCMV or infected cells did not upregulate reactive oxygen species (data not shown), and iNOS, IFNs, iNOS, and TNF-a did not participate singularly in neutrophil antiviral activity. Instead, inhibition of FasL moderately inhibited antiviral function, suggesting neutrophils restrict MCMV via expression of TNFSF proteins.
Neutrophils receive activation signals during migration into inflamed tissue (Futosi et al., 2013) , suggesting their activation in MCMV infection may be independent of virus recognition. Indeed, TRAIL expression by neutrophils is rapidly induced by IFNs (Koga et al., 2004; Tecchio et al., 2004) . Although neutralization of individual IFNs did not abrogate anti-MCMV neutrophil activity in vitro, it is possible that multiple antiviral cytokines induce antiviral neutrophil activity in vivo without the requirement for pattern recognition receptor-mediated neutrophil activation.
IL-22R expression determined the tissue-restricted influence of IL-22 on antiviral immunity. However, neutrophil depletion in WT mice also uncovered an organ-restricted antiviral role for neutrophils, with no obvious role for neutrophils in splenic MCMV infection. CXCL1 did not influence neutrophil accumulation within the spleen. Differences in orchestration of splenic versus pulmonary and hepatic neutrophil responses may influence their ability to counter MCMV. MCMV cell tropism within different organs may also influence neutrophil antiviral control. Stromal cells are targeted by MCMV in the spleen (Hsu et al., 2009; Schneider et al., 2008; Verma et al., 2013) , and responsiveness of these cells to effector molecules produced by neutrophils may differ from infected cells in the liver and lung. Moreover, the efficiency of viral evasion mechanisms may vary in different cell types, influencing the efficacy of neutrophil antiviral control. Importantly, however, neutrophil depletion in RAG À/À mice elevated splenic virus load, demonstrating that neutrophils can limit MCMV infection in the spleen when present in large numbers. Given the antiviral role of neutrophils, it is surprising that HCMV encodes a homolog of the neutrophil-attractant chemokine CXCL1 (UL146), hypothesized to promote neutrophil recruitment to facilitate HCMV dissemination (Penfold et al., 1999) . Host survival in acute infection is essential for establishment of virus persistence and dissemination. Thus, neutrophil limitation of acute infection facilitated by UL146 may be a necessary evil to enable virus chronicity and transmission. Alternatively, UL146 may act preferentially in certain contexts, for example by promoting neutrophil adherence to virus-infected vascular endothelium, but exert less influence within peripheral organs where, as demonstrated in MCMV infection, mammalian CXCL1 is expressed at biologically significant levels. Importantly, MCMV did not productively replicate within neutrophils ( Figure S4D ). Moreover, we detected very few neutrophils in the salivary glands at the onset of virus persistence (data not shown), supporting the hypothesis that monocytes rather than neutrophils disseminate MCMV (Stoddart et al., 1994) . Given that CXCL1 promotes recruitment of nonneutrophils (Tsai et al., 2002) , our data imply that UL146 may have a function distinct from neutrophil recruitment.
Of note, MCMV-infected IL-22R À/À mice did not exhibit heightened virus load, reduced neutrophil recruitment, or CXCL1 protein in peripheral sites of infection (data not shown). Numerous cytokines can induce proinflammatory chemokines, and heightened proinflammatory cytokine and chemokine responses have been reported following viral infection of IL-22 À/À mice (Guabiraba et al., 2013) , suggesting that alternate proinflammatory/antiviral mechanisms compensate for the absence of the IL-22R signaling in knockout mice, whereas such compensatory mechanisms are absent after IL-22 neutralization in WT mice. Although NK1.1 depletion revealed that NK and NK T cells secrete virus-induced IL-22, concurrent depletion of NK cells and neutrophils had an additive effect on elevating virus load. Moreover, we observed no decrease in neutrophil recruitment after NK cell depletion (data not shown). Although IL-22 neutralization in neutrophil-depleted mice failed to further increase virus load, suggesting a dominant role of neutrophil recruitment in the antiviral activity of IL-22. However, our study does not preclude the existence of additional antiviral pathways elicited by IL-22R signaling. IL-22 exerts a vast range of biological activities (Ouyang et al., 2011; Sonnenberg et al., 2011; Zenewicz et al., 2007) . Indeed, during HIV and influenza infections, IL-22 limits epithelial cell damage at mucosal surfaces Kumar et al., 2013) . Given the critical role of mucosal surfaces in herpesvirus dissemination and pathogenesis, the role that IL-22 may play in acute and chronic infection of the mucosa warrants further investigation.
In summary, we identify IL-22 as a critical antiviral effector cytokine in peripheral sites of MCMV infection and identified the recruitment of neutrophils as a mechanism through which IL-22 affords antiviral protection. These data define neutrophils as an important antiviral effector cell population that acts during the initial stages of CMV infection and uncover the TRAIL/ TRAILR pathway as a mechanism through which neutrophils exert antiviral control.
EXPERIMENTAL PROCEDURES
Mice, Viral Infections, and Treatments All experiments were conducted under a UK Home Office project license (PPL 30/2442 and 30/2969). WT C57BL/6 mice were purchased (Harlan), RAG1 À/À mice were bred in-house, IL-22 À/À mice were kindly provided by Jean-Christophe Renauld (Ludwig Institute, Brussels), and IL-22RA1 reporter mice were generated as described in the Supplemental Experimental Procedures. MCMV Smith strain (ATCC) was prepared in BALB/c salivary glands and purified over a sorbital gradient. Virus from homogenized organs and tissue culture supernatants were titered on 3T3 cells. Mice were infected intraperitoneally (i.p.) with 3 3 10 4 pfu MCMV and weighed daily. Some mice were injected i.p. with 200 mg aNK1.1 (clone PK136, BioXCell) or IgG control on days À2, 0, and +2 p.i. For T cell depletion, mice were injected (i.p.) with 200 mg aCD4 antibody (100 mg clone YTS191, 100 mg clone YTS3) and 200 mg aCD8 antibody (100 mg clone YTS156, 100 mg clone YTS169, all in-house). Neutrophils were depleted with 100 mg aLy6G (clone 1A8, BioXCell); for TRAIL neutralization mice were administered 250 mg of aTRAIL (clone N2B2, Biolegend), and for IL-22 neutralization mice were administered i.v. 50 mg goat IgG (Chemicon) or aIL-22 (R&D Systems). Some mice were treated with 100 mg IgG or aCXCL1 (clone 124014, R&D Systems). All administrations were day 0 and, for 4-day experiments, 2 p.i.
Flow Cytometry
Leukocytes were isolated from murine tissue as previously described (Stacey et al., 2011) and stained with Live/Dead Fixable Aqua (Invitrogen), incubated with Fc block (eBioscience), and stained for surface markers with a combination of antibodies listed in the Supplemental Experimental Procedures. To detect IL-22-secreting cells, cells were incubated in brefeldin A (SigmaAldrich) ± IL-23 (50 mg/ml, R&D Systems) ± 50 ng/ml PMA and 500 ng/ml ionomycin (both Sigma-Aldrich) prior to surface staining and permeabilization with saponin buffer, stained with aIL-22, aIFN-g, agranzyme B, and/or aRORgT. To measure CD11b expression by neutrophils, tissues remained on ice during processing and red blood cells were not lysed, to avoid cell stimulation prior to staining. For TRAILR expression analysis, fibroblasts were infected with MCMV at a moi of 0.2 and stained with aTRAILR (clone 5D5-1, eBioscience). Further details are provided in the Supplemental Experimental Procedures.
Cytokine/Chemokine Protein Measurement Excized lungs, livers, and spleens ($50 mg) were weighed, washed in PBS, and homogenized in DMEM. Supernatants were assayed for cytokines by cytometric bead array (eBioscience) or, for IL-22 and CXCL1, ELISA (eBioscience and R&D Systems, respectively). In some experiments, 3T3 fibroblasts and SGC1 cells (determined by FACS to be IL-22R À and IL-22R + , respectively, data not shown) were infected with MCMV (moi 0.5) or treated with 50 ng/ml IL-22 (R&D Systems) for 30 min prior to washing. CXCL1 protein was assayed by ELISA after 6 hr.
Histological Analysis
To identify IL-22RA + cells, tissue sections from WT and IL-22ra1-LacZ mice were stained overnight in 0.1% (w/v) 5-bromo-4-chloro-3-indolyl-beta-Dgalactosidase (X-gal; Invitrogen), and reporter activity identified under light microscopy (Zeiss Axiovert 200M) with AxioVision version 4.8.2 software. Neutrophil colocalization was assessed in paraffin-embedded liver sections stained with am123 and aLy6G and visualized with DAB (Vector Labs) and VIP Chromogen solution (Vector Labs), respectively. Further details are in the Supplemental Experimental Procedures.
Assessment of Gene Expression
RNA was extracted from tissue by RNA easy kit (QIAGEN), cDNA synthesized with a TaqMan reverse transcription kit (Applied Biosystems), and gene expression determined by quantitative PCR using a Mini Opticon (Bio-Rad) and Platinum SYBR green mastermix reagent (Biorad), using primers listed in Table S1 .
Assessment of Neutrophil Antiviral Activity
Splenic neutrophils were purified from RAG À/À mice using a negative selection kit (Stemcell technologies) and a positive selection kit (Miltenyi Biotec) as described in the Supplemental Experimental Procedures, and incubated with MCMV-infected 3T3s (moi 0.02). MCMV in supernatants was measured 7 days later by plaque assay. Freeze-thawed neutrophils were nonviable controls. Some wells received inhibitory reagents: aTRAIL (10 mg/ml, clone N2B2, Biolegend), aFasL (10 mg/ml, clone 101626, R&D Systems), aIFNa (10 mg/ml, clone RMMA-1, PBL Interferon Source), aIFNb (10 mg/ml, clone RMMB-1, PBL Interferon Source), aIFNg (10 mg/ml, clone XMG1.2, in house), aTNF-a (10 mg/ml, XT22, in house), and iNOS inhibitors (10 mM, 1400W, SigmaAldrich). Some MCMV-infected fibroblasts were treated with TRAIL or FAS (R&D Systems) at concentrations stated in Figure 7 .
Statistics
Statistical significance was determined using the Mann-Whitney U test (viral load analysis) or the two-tailed Student's t test (weight loss, flow cytometry, ELISA); *p % 0.05, **p % 0.01, ***p % 0.001. 
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